CD
Chai DiscoveryChai Discovery builds generative AI foundation models that predict and design protein and antibody structures to accelerate pre-clinical drug discovery.
2 Pulse stories
EM
Encore MedicalEncore Medical develops transcatheter septal occlusion devices to repair structural heart defects like patent foramen ovale (PFO).
2 Pulse stories
Total Raised
$600M
Chai DiscoveryEncore Medical
Last Valuation
$3.8B
Chai DiscoveryEncore Medical
Biotech
Sector
Biotech
2024
Founded
2017
San Francisco, CA
HQ
Eagan, Minnesota
Private
Status
Public (EMI)
Chai Discovery investors
Index VenturesSequoia CapitalDimensionKleiner Perkins
Encore Medical investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for Chai Discovery and Encore Medical.